TickerGuard
Buy Day today: Neutral (54) Mixed market breadth · no major macro event
SLN

Silence Therapeutics PLC

Healthcare · Biotechnology

10.80$ -3.6% vs. previous close Closing price · As of: Sep 29, 2026

Statements

Balance Sheet

Silence Therapeutics PLC (SLN) by the numbers: income statement, balance sheet and cash flow, by year or by quarter. In the most recent period (2025), "Total Assets" came in at 131 million USD. Tick rows to compare them in a chart.

All figures in millions of USD.

Tick rows to compare them in a chart (up to 4)

Balance Sheet SLN
Line item 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025
30 62 56 55 39 46 86 96 108 95 162 131
22 54 42 46 29 37 76 86 97 82 150 119
17 52 39 43 21 14 27 74 55 54 97 11
22 52 39 43 27 34 37 74 71 54 118 85
0.4 1.5 0.8 2.0 2.4 0.0 29 0.3 0.9 19 0.8 25
-0.4 -1.6 -3.0 -2.5 -2.4 – 1.5 0.0 -16 -19 – –
– – 1.4 1.2 0.9 0.6 1.1 1.9 2.2 – – –
7.1 6.7 7.7 8.0 8.1 7.7 8.1 7.6 8.0 10.0 7.5 11
0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.3 0.4 0.2 0.3
2.0 1.1 1.6 2.7 3.8 25 77 88 85 77 55 69
2.0 1.1 1.6 2.7 3.8 9.7 26 15 22 18 13 14
1.5 – – – – 0.3 0.3 0.1 0.4 0.2 0.1 0.1
2.0 0.2 0.5 0.5 1.1 1.8 2.3 4.1 3.2 2.6 3.0 4.4
28 60 54 52 35 21 9.1 8.5 22 22 107 62
-103 -109 -116 -116 -134 -152 -184 -223 -263 -432 -379 -563
17 21 23 23 23 25 27 30 11 12 15 16

Data as of: September 29, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)

Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.

Was this page helpful to you?